InvestorsHub Logo
Followers 3
Posts 171
Boards Moderated 0
Alias Born 12/28/2017

Re: Bobby Marinov post# 5962

Monday, 05/20/2019 1:14:23 PM

Monday, May 20, 2019 1:14:23 PM

Post# of 6602
Great Question, the 500ft view looks actually fairly good. Milestones with Asia are: breaking ground on the plant in China and/or purchase/rentals/clinical trails like Singapore. Great to see we have a person in relatively short order leading that charge, Ms. Lim Foon. The institutional sponsorship is good this will help offset any dilution but some of the positions are somewhat small I have owned more than some of these, need to watch very closely who adds and who drop off. Additionally we need more than 2 B/D's on the conference call another piece missing in sponsorship. The new sales people and Mr. Shaw could be a key addition IMO if we had triple digit sales gains that $5.+ that's and that turns analysts heads.....Majestic I believe was correct expectations were higher but solid progress for the Q.

Headwinds are still no traction in the space, I believe and we all bet this will change. The competitors haven't been fairing to well MYO, RWLK, and BNKL. China trade war doesn't help.

At the 100 ft level this is real short term







Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EKSO News